21.05.2013 07:35 Uhr, Quelle: Wallstreet online

DGAP-News: Press Release: 4SC's partner Yakult Honsha starts clinical Phase I/II study with cancer compound resminostat in liver cancer in Japan

DGAP-News: 4SC AG / Key word(s): Miscellaneous Press Release: 4SC's partner Yakult Honsha starts clinical Phase I/II study with cancer compound resminostat in liver cancer in Japan (with additional features) 21.05.2013 / …

Weiterlesen bei Wallstreet online